|
|
||||||||
J Thorac Cardiovasc Surg 2009;137:907-913
© 2009 The American Association for Thoracic Surgery
Congenital Heart Disease |
a Cardiac Surgery Research Laboratories, The Children's Mercy Hospitals and Clinics, Kansas City, Mo
b LifeNet Health, Virginia Beach, Va
c Brown University Medical School, Providence, RI
Received for publication June 19, 2008; revisions received November 7, 2008; accepted for publication December 19, 2008. * Address for reprints: Richard A. Hopkins, MD, Children's Mercy Hospitals and Clinics, 2401 Gillham Rd, Kansas City, MO 64108. (Email: rahopkins{at}cmh.edu).
Objective: The juvenile sheep functional valve chronic implant calcification model was used to compare long-term calcification rates, functional performance, and durability for 3 types of right ventricular outflow tract implants: classically cryopreserved homografts and 2 decellularized pulmonary valved conduits.
Methods: Fifteen juvenile sheep were randomly assigned to one of 3 study arms and underwent pulmonary valve replacement. The arms included the following: (1) cryopreserved ovine pulmonary valves; (2) cryopreserved, decellularized, saline (1°C–10°C)–stored ovine pulmonary valves; and (3) cryopreserved, decellularized, glycerolized (–80°C) stored ovine pulmonary valves. Animal growth, serial echocardiographic results (with valve performance assessment), dimensions, and tissue-specific calcification measurements were compared with pre-explant angiographic analysis and right ventricular outflow tract pressure measurements, cardiac magnetic resonance imaging, specimen radiographic analysis, gross explant pathology, and histopathology. Parametric and nonparametric statistical analysis were performed.
Results: All but 2 study animals receiving implants thrived postoperatively, with similar growth rates, explant valve dimensions, ventricular functions, cardiac output, and indices during the study. As determined by means of echocardiographic analysis, 3 animals in arm 1 (and one in arm 2) had leaflet dysfunction. Valve regurgitation was recognized in 1 survivor each from both arms 1 and 2. Although 1 arm 1 animal died with calcified subacute bacterial endocarditis, and the other 4 had leaflet and conduit wall calcification by the time of death, no arm 2 or arm 3 animals demonstrated leaflet calcium, and no arm 3 and only 1 arm 2 animals had calcium in the conduit wall over the entire year, as determined with any measurement method. All cryopreserved conduit walls had calcium by 20 weeks, whereas only 1 of 10 decellularized conduits (arms 2 plus 3) had wall calcium.
Conclusion: Cryopreserved–decellularized–glycerolized valves retained normal valve function, with absent leaflet and minimal wall calcifications 1 year postoperatively, as opposed to classically cryopreserved allografts. These results might be predictive of the prolonged durability and functionality of a cryopreserved–decellularized–glycerolized allograft valve.
This article has been cited by other articles:
![]() |
R. W. Quinn, S. L. Hilbert, A. A. Bert, B. W. Drake, J. A. Bustamante, J. E. Fenton, S. J. Moriarty, S. L. Neighbors, G. K. Lofland, and R. A. Hopkins Performance and Morphology of Decellularized Pulmonary Valves Implanted in Juvenile Sheep Ann. Thorac. Surg., July 1, 2011; 92(1): 131 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Flameng, R. Jashari, G. De Visscher, L. Mesure, and B. Meuris Calcification of allograft and stentless xenograft valves for right ventricular outflow tract reconstruction: An experimental study in adolescent sheep J. Thorac. Cardiovasc. Surg., June 1, 2011; 141(6): 1513 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Lehr, G. R. Rayat, B. Chiu, T. Churchill, L. E. McGann, J. Y. Coe, and D. B. Ross Decellularization reduces immunogenicity of sheep pulmonary artery vascular patches J. Thorac. Cardiovasc. Surg., April 1, 2011; 141(4): 1056 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. M. Dahl, A. P. Kypson, J. H. Lawson, J. L. Blum, J. T. Strader, Y. Li, R. J. Manson, W. E. Tente, L. DiBernardo, M. T. Hensley, et al. Readily Available Tissue-Engineered Vascular Grafts Science Translational Medicine, February 2, 2011; 3(68): 68ra9 - 68ra9. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Akhyari, H. Kamiya, P. Gwanmesia, H. Aubin, R. Tschierschke, S. Hoffmann, M. Karck, and A. Lichtenberg In vivo functional performance and structural maturation of decellularised allogenic aortic valves in the subcoronary position, Eur J Cardiothorac Surg, November 1, 2010; 38(5): 539 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gottlieb, T. Kunal, S. Emani, E. Aikawa, D. W. Brown, A. J. Powell, A. Nedder, G. C. Engelmayr Jr., J. M. Melero-Martin, M. S. Sacks, et al. In vivo monitoring of function of autologous engineered pulmonary valve J. Thorac. Cardiovasc. Surg., March 1, 2010; 139(3): 723 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Elefteriades Should We Abandon Homografts? J. Am. Coll. Cardiol., January 26, 2010; 55(4): 377 - 378. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |